Corticotropin releasing factor antagonists
US6833378B2 · kind B2 · utility
14Cited by
6References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 17, 2001 |
| Grant date | Dec 21, 2004 |
| Priority date | — |
| Expiry date | Mar 12, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Corticotropin-releasing factor (CRF) antagonists having the formulae wherein the dashed lines, A, B, Y, Z, G, R3, R4, R5, R6, R16 and R17 are as defined in the application, and processes for preparing them. These compounds and their pharmaceutically acceptable salts are useful in the treatment disorders including CNS and stress-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.